Viewing Study NCT05067166

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 4:04 PM

Ignite Modification Date: 2025-12-28 @ 9:56 PM

Study NCT ID: NCT05067166

Status: AVAILABLE

Last Update Posted: 2024-12-17

First Post: 2021-09-23

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Open-Label Expanded Access for Ebola-Infected Patients to Receive Human MAb Ansuvimab As Therapeutic or for HR PEP

Sponsor: Ridgeback Biotherapeutics, LP

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module